Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91


Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.

Hu X, Hu Y, Zhao C, Gao H, Greene KM, Ren L, Ma L, Ruan Y, Sarzotti-Kelsoe M, Montefiori DC, Hong K, Shao Y.

Sci Rep. 2017 Apr 7;7:46308. doi: 10.1038/srep46308.


Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

Hu X, Hong K, Zhao C, Zheng Y, Ma L, Ruan Y, Gao H, Greene K, Sarzotti-Kelsoe M, Montefiori DC, Shao Y.

J Gen Virol. 2012 Oct;93(Pt 10):2267-78. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.


Neutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China.

OuYang Y, Sun J, Huang Y, Lu L, Xu W, Hu X, Hong K, Jiang S, Shao Y, Ma L.

Virol J. 2013 Jan 5;10:10. doi: 10.1186/1743-422X-10-10.


Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.

Wang S, Nie J, Wang Y.

Virus Res. 2011 Jan;155(1):137-46. doi: 10.1016/j.virusres.2010.09.012. Epub 2010 Sep 25.


Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).

Bao MJ, Geng WQ, Cui HL, Zhang XL, Xu DB, Nian H, Dai D, Wang YN, Shang H.

Mol Med Rep. 2012 May;5(5):1311-7. doi: 10.3892/mmr.2012.790. Epub 2012 Feb 14.


Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China.

Ma L, Guo Y, Yuan L, Huang Y, Sun J, Qu S, Yu X, Meng Z, He X, Jiang S, Shao Y.

Retrovirology. 2009 May 14;6:45. doi: 10.1186/1742-4690-6-45.


Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.

Kong R, Li H, Bibollet-Ruche F, Decker JM, Zheng NN, Gottlieb GS, Kiviat NB, Sow PS, Georgiev I, Hahn BH, Kwong PD, Robinson JE, Shaw GM.

J Virol. 2012 Jan;86(2):947-60. doi: 10.1128/JVI.06155-11. Epub 2011 Oct 26.


Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India.

Hussain SI, Panneerselvam N, Solomon S, Solomon SS, Adam K, Chandrasekaran E, Montefiori DC, Pachamuthu B.

J Int Assoc Provid AIDS Care. 2017 Mar/Apr;16(2):201-208. doi: 10.1177/1545109712467695. Epub 2016 Jul 7.


Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B' env molecular clones derived from infections in China.

Xie H, Nie J, Chen Q, Huang W, Wang Y.

Emerg Microbes Infect. 2018 May 16;7(1):90. doi: 10.1038/s41426-018-0087-0.


Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.

Wagner GA, Landais E, Caballero G, Phung P, Kosakovsky Pond SL, Poignard P, Richman DD, Little SJ, Smith DM.

J Virol. 2017 Aug 10;91(17). pii: e00475-17. doi: 10.1128/JVI.00475-17. Print 2017 Sep 1.


Genetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in China.

Chong H, Hong K, Zhang C, Nie J, Song A, Kong W, Wang Y.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):535-43. doi: 10.1097/QAI.0b013e3181663967.


Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.

Jacob RA, Moyo T, Schomaker M, Abrahams F, Grau Pujol B, Dorfman JR.

J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.


Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India.

Makhdoomi MA, Khan L, Kumar S, Aggarwal H, Singh R, Lodha R, Singla M, Das BK, Kabra SK, Luthra K.

J Gen Virol. 2017 Jul;98(7):1879-1891. doi: 10.1099/jgv.0.000824. Epub 2017 Jul 12.


Cross-neutralizing antibody profile of Chinese HIV-1-infected individuals and the viral envelope features from elite neutralizers.

Ren C, Liu S, Li Y, Zhuang M, Yu H, Wang J, Sun F, Li D, Zhang H, Liu W, Liang S, Zhong P, Ling H.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):472-80. doi: 10.1097/QAI.0000000000000345.


Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China.

Shang H, Han X, Shi X, Zuo T, Goldin M, Chen D, Han B, Sun W, Wu H, Wang X, Zhang L.

J Biol Chem. 2011 Apr 22;286(16):14531-41. doi: 10.1074/jbc.M111.224527. Epub 2011 Feb 16.


Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.

Patil S, Kumar R, Deshpande S, Samal S, Shrivastava T, Boliar S, Bansal M, Chaudhary NK, Srikrishnan AK, Murugavel KG, Solomon S, Simek M, Koff WC, Goyal R, Chakrabarti BK, Bhattacharya J.

J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.


Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.

Murphy MK, Yue L, Pan R, Boliar S, Sethi A, Tian J, Pfafferot K, Karita E, Allen SA, Cormier E, Goepfert PA, Borrow P, Robinson JE, Gnanakaran S, Hunter E, Kong XP, Derdeyn CA.

PLoS Pathog. 2013 Feb;9(2):e1003173. doi: 10.1371/journal.ppat.1003173. Epub 2013 Feb 28.


The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.

Cornelissen M, Euler Z, van den Kerkhof TL, van Gils MJ, Boeser-Nunnink BD, Kootstra NA, Zorgdrager F, Schuitemaker H, Prins JM, Sanders RW, van der Kuyl AC.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1135-1142. Epub 2016 Feb 24.


Serum neutralizing activities from a Beijing homosexual male cohort infected with different subtypes of HIV-1 in China.

Zhang M, Jiao Y, Wang S, Zhang L, Huang Z, Chen Y, Wu H.

PLoS One. 2012;7(10):e47548. doi: 10.1371/journal.pone.0047548. Epub 2012 Oct 18.

Supplemental Content

Support Center